| CPC A61K 48/005 (2013.01) [C12N 9/22 (2013.01); C12N 15/102 (2013.01); C12N 15/11 (2013.01); C12N 15/86 (2013.01); C12N 15/907 (2013.01); C12N 2310/20 (2017.05); C12N 2750/14143 (2013.01)] | 16 Claims |

|
1. A method of producing an altered dystrophin gene product in a eukaryotic cell within a mammal comprising
providing to the eukaryotic cell one or more nucleic acid molecules encoding two or more guide RNAs complementary to two or more target genomic dystrophin DNA sequences flanking one or more exons of exons 45-55 of a target dystrophin gene, and
wherein the one or more nucleic acid molecules encode a Cas9 protein,
wherein the one or more nucleic acid molecules are expressed in the eukaryotic cell,
wherein the two or more guide RNAs bind to the two or more sequences on the target dystrophin gene and the Cas9 protein cleaves at the two or more sequences thereby removing the one or more exons from the target dystrophin gene to produce an altered dystrophin gene,
wherein the two or more guide RNAs are each a tracrRNA-crRNA fusion comprising
| |||||||||
wherein the eukaryotic cell expresses the altered dystrophin gene to produce a truncated dystrophin polypeptide.
|